| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ADRA2C
|
adrenoceptor alpha 2C
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ANKFN1
|
ankyrin-repeat and fibronectin type III domain containing 1
|
|
ANKK1
|
ankyrin repeat and kinase domain containing 1
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BPTF
|
bromodomain PHD finger transcription factor
|
|
C17ORF58
|
chromosome 17 open reading frame 58
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
|
CHRM3
|
cholinergic receptor, muscarinic 3
|
|
CHRNA3
|
cholinergic receptor, nicotinic, alpha 3 (neuronal)
|
|
CHRNA5
|
cholinergic receptor, nicotinic, alpha 5 (neuronal)
|
|
CHRNB4
|
cholinergic receptor, nicotinic, beta 4 (neuronal)
|
|
CHST1
|
carbohydrate (keratan sulfate Gal-6) sulfotransferase 1
|
|
CHST2
|
carbohydrate (N-acetylglucosamine-6-O) sulfotransferase 2
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
COMT
|
catechol-O-methyltransferase
|
|
DAOA
|
D-amino acid oxidase activator
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DRD1
|
dopamine receptor D1
|
|
DRD2
|
dopamine receptor D2
|
|
DRD3
|
dopamine receptor D3
|
|
DRD4
|
dopamine receptor D4
|
|
DTNBP1
|
dystrobrevin binding protein 1
|
|
EHMT1
|
euchromatic histone-lysine N-methyltransferase 1
|
|
EHMT2
|
euchromatic histone-lysine N-methyltransferase 2
|
|
FAAH
|
fatty acid amide hydrolase
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FKBP5
|
FK506 binding protein 5
|
|
GABRA2
|
gamma-aminobutyric acid (GABA) A receptor, alpha 2
|
|
GABRA6
|
gamma-aminobutyric acid (GABA) A receptor, alpha 6
|
|
GAD1
|
glutamate decarboxylase 1 (brain, 67kDa)
|
|
GPM6A
|
glycoprotein M6A
|
|
GRM3
|
glutamate receptor, metabotropic 3
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
LRRTM1
|
leucine rich repeat transmembrane neuronal 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTR
|
5-methyltetrahydrofolate-homocysteine methyltransferase
|
|
MTRR
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NPY
|
neuropeptide Y
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NRG1
|
neuregulin 1
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
PENK
|
proenkephalin
|
|
PIP4K2A
|
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha
|
|
POMC
|
proopiomelanocortin
|
|
PPM1D
|
protein phosphatase, Mg2+/Mn2+ dependent, 1D
|
|
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B
|
|
PRDM2
|
PR domain containing 2, with ZNF domain
|
|
PRODH
|
proline dehydrogenase (oxidase) 1
|
|
RGS17
|
regulator of G-protein signaling 17
|
|
RGS2
|
regulator of G-protein signaling 2
|
|
RGS20
|
regulator of G-protein signaling 20
|
|
RGS4
|
regulator of G-protein signaling 4
|
|
ROBO1
|
roundabout, axon guidance receptor, homolog 1 (Drosophila)
|
|
SLC18A2
|
solute carrier family 18 (vesicular monoamine transporter), member 2
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
TBX1
|
T-box 1
|
